B

BMP Pharma Trading AG
XBER:BMP

Watchlist Manager
BMP Pharma Trading AG
XBER:BMP
Watchlist
Price: 5.3 EUR Market Closed
Market Cap: 27.8m EUR

Operating Margin

-28 006.7%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-28 006.7%
=
Operating Income
€-1.3m
/
Revenue
€4.5k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-28 006.7%
=
Operating Income
€-1.3m
/
Revenue
€4.5k

Peer Comparison

Country Company Market Cap Operating
Margin
DE
BMP Pharma Trading AG
XBER:BMP
27.8m EUR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.3B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
386.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...

Market Distribution

Lower than 99% of companies in Germany
Percentile
1st
Based on 3 747 companies
1st percentile
-28 006.7%
Low
-61 459.6% — 0.7%
Typical Range
0.7% — 9.8%
High
9.8% — 94 540%
Distribution Statistics
Germany
Min -61 459.6%
30th Percentile 0.7%
Median 4.5%
70th Percentile 9.8%
Max 94 540%

BMP Pharma Trading AG
Glance View

Market Cap
27.8m EUR
Industry
N/A

B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.

BMP Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-28 006.7%
=
Operating Income
€-1.3m
/
Revenue
€4.5k
How has Operating Margin changed over time?

Over the last 3 years, BMP Pharma Trading AG’s Operating Margin has decreased from -6 664% to -28 006.7%. During this period, it reached a low of -62 327.3% on Dec 31, 2019 and a high of -6 664% on May 30, 2019.

Back to Top